Prophylactic cranial irradiation
Prophylactic Cranial Irradiation[edit | edit source]
Prophylactic Cranial Irradiation (PCI) is a preventive medical procedure used primarily in patients with certain types of cancer, such as small cell lung cancer (SCLC), to reduce the risk of metastasis to the brain. PCI involves the administration of radiation therapy to the entire brain, even when there is no evidence of cancer spread to the brain at the time of treatment.
Indications[edit | edit source]
PCI is most commonly indicated in patients with SCLC who have achieved a complete or partial response to initial therapy. The rationale for PCI in these patients is based on the high incidence of brain metastases in SCLC and the poor prognosis associated with such metastases. By irradiating the brain prophylactically, the risk of developing brain metastases is significantly reduced, which can improve overall survival and quality of life.
Procedure[edit | edit source]
The procedure for PCI involves the use of external beam radiation therapy. Patients typically undergo a series of treatment sessions over several weeks. The total dose of radiation and the fractionation schedule can vary, but common regimens include 25 Gy delivered in 10 fractions.
During the procedure, patients are positioned on a treatment table, and a custom mask may be used to immobilize the head and ensure precise delivery of radiation. The radiation is delivered using a linear accelerator, and the entire brain is targeted.
Side Effects[edit | edit source]
While PCI can be effective in reducing the risk of brain metastases, it is associated with several potential side effects. Acute side effects may include fatigue, nausea, and headache. Long-term side effects can include cognitive decline, memory impairment, and other neurocognitive deficits. The risk of these side effects must be weighed against the potential benefits of the procedure.
Alternatives[edit | edit source]
Alternatives to PCI include regular magnetic resonance imaging (MRI) surveillance of the brain and treatment of brain metastases if and when they occur. This approach may be preferred in patients who are at higher risk for neurocognitive side effects or in those who decline PCI.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
